Advertisement

Ultrasound-Guided Localization of Nonpalpable Lesions

  • Bruno D. Fornage
Chapter
  • 55 Downloads

Abstract

In the same way that it has revolutionized the detection and percutaneous biopsy of minute nonpalpable breast masses, ultrasound (US) has revolutionized the preoperative localization of these masses for the surgeon. Localization of nonpalpable breast lesions can be done preoperatively in the breast imaging section, immediately prior to surgery in the operating room, or even during surgery. This chapter covers the various US-guided localization techniques that are available today, which range from US-directed skin marking of the projection of a not-too-deep lesion or usage of a US scanner during surgery to sophisticated and expensive new technique, such as the preoperative US-guided insertion of radioactive or magnetic seeds.

Keywords

Needle localization Wire localization Methylene blue India ink Carbon black suspension Radioactive seed localization Limitations Complications Skin marking Intraoperative ultrasound localization Ex vivo scanning of the specimen Cryoprobe-assisted lumpectomy Magnetic seed localization Savi SCOUT device Radiofrequency identification tag 

Supplementary material

Video 19.1

Insertion of a radioactive seed in a small T1 invasive ductal carcinoma prior to segmentectomy. The seed appears as a long linear echo casting some shadowing (see also Fig. 19.11). (MP4 10545 kb)

Video 19.2a

Intraoperative color Doppler US performed to identify the vascular pedicle of a transverse rectus abdominis myocutaneous flap, follow its course, and determine its relationship with a recurrent myoepithelial carcinoma prior to resection (see also Fig. 19.21). On longitudinal scanning, the artery is identified from its origin in the second intercostal space, is followed as it courses over the third rib, and is then followed inferiorly as it passes lateral to the tumor. (MP4 39305 kb)

Video 19.2b

Intraoperative color Doppler US performed to identify the vascular pedicle of a transverse rectus abdominis myocutaneous flap, follow its course, and determine its relationship with a recurrent myoepithelial carcinoma prior to resection (see also Fig. 19.21). On transverse scanning, the pedicle is followed from its origin in the second intercostal space downward and is seen coursing lateral to the tumor, at a distance of only a few millimeters. (MP4 17259 kb)

References

  1. 1.
    Gold RH, Bassett LW, Widoff BE. Highlights from the history of mammography. Radiographics. 1990;10(6):1111–31.PubMedCrossRefGoogle Scholar
  2. 2.
    Dodd GD, Fry K, Delany W. Preoperative localization of occult carcinoma of the breast. In: Management of the patient with cancer. Philadelphia: W. B. Saunders Co; 1966.Google Scholar
  3. 3.
    Fornage BD, Ross MI, Singletary SE, Paulus DD. Localization of impalpable breast masses: value of sonography in the operating room and scanning of excised specimens. AJR Am J Roentgenol. 1994;163(3):569–73.CrossRefPubMedGoogle Scholar
  4. 4.
    Park JY, Park NH, Yi SY, Ko MS, Park HJ. Preoperative US-guided hookwire localization for nonpalpable cervical masses. J Clin Ultrasound. 2012;40(4):195–9.Google Scholar
  5. 5.
    Egan JF, Sayler CB, Goodman MJ. A technique for localizing occult breast lesions. CA Cancer J Clin. 1976;26(1):32–7.Google Scholar
  6. 6.
    Berridge DL, Mastey LA, Eckstrom PC, Czarnecki DJ. Indocyanine green dye as a tissue marker for localization of nonpalpable breast lesions. AJR Am J Roentgenol. 1995;164(5):1299.PubMedCrossRefGoogle Scholar
  7. 7.
    Czarnecki DJ, Feider HK, Splittgerber GF. Toluidine blue dye as a breast localization marker. AJR Am J Roentgenol. 1989;153(2):261–3.PubMedCrossRefGoogle Scholar
  8. 8.
    Luigiano C, Ferrara F, Morace C, Mangiavillano B, Fabbri C, Cennamo V, et al. Endoscopic tattooing of gastrointestinal and pancreatic lesions. Adv Ther. 2012;29(10):864–73.PubMedCrossRefGoogle Scholar
  9. 9.
    Nasrinossadat A, Ladan F, Fereshte E, Asieh O, Reza C, Akramossadat S, et al. Marking non-palpable breast masses with injected methylene blue dye, an easy, safe and low cost method for developing countries and resource-limited areas. Asian Pac J Cancer Prev. 2011;12(5):1189–92.Google Scholar
  10. 10.
    Svane G. A stereotaxic technique for preoperative marking of non-palpable breast lesions. Acta Radiol Diagn. 1983;24(2):145–51.PubMedCrossRefGoogle Scholar
  11. 11.
    Mazy S, Galant C, Berliere M, Mazy G. Localization of non-palpable breast lesions with black carbon powder (experience of the Catholic University of Louvain). J Radiol. 2001;82(2):161–4. Google Scholar
  12. 12.
    Gray RJ, Pockaj BA, Karstaedt PJ, Roarke MC. Radioactive seed localization of nonpalpable breast lesions is better than wire localization. Am J Surg. 2004;188(4):377–80.PubMedCrossRefGoogle Scholar
  13. 13.
    Hughes JH, Mason MC, Gray RJ, McLaughlin SA, Degnim AC, Fulmer JT, et al. A multi-site validation trial of radioactive seed localization as an alternative to wire localization. Breast J. 2008;14(2):153–7.PubMedCrossRefGoogle Scholar
  14. 14.
    Jakub JW, Gray RJ, Degnim AC, Boughey JC, Gardner M, Cox CE. Current status of radioactive seed for localization of non palpable breast lesions. Am J Surg. 2010;199(4):522–8. PubMedCrossRefGoogle Scholar
  15. 15.
    Lovrics PJ, Goldsmith CH, Hodgson N, McCready D, Gohla G, Boylan C, et al. A multicentered, randomized, controlled trial comparing radioguided seed localization to standard wire localization for nonpalpable, invasive and in situ breast carcinomas. Ann Surg Oncol. 2011;18(12):3407–14.PubMedCrossRefGoogle Scholar
  16. 16.
    Sung JS, King V, Thornton CM, Brooks JD, Fry CW, El-Tamer M, et al. Safety and efficacy of radioactive seed localization with I-125 prior to lumpectomy and/or excisional biopsy. Eur J Radiol. 2013;82(9):1453–7.PubMedCrossRefGoogle Scholar
  17. 17.
    Chan BK, Wiseberg-Firtell JA, Jois RH, Jensen K, Audisio RA. Localization techniques for guided surgical excision of non-palpable breast lesions. Cochrane Database Syst Rev. 2015;12:CD009206.Google Scholar
  18. 18.
    Barentsz MW, van den Bosch MA, Veldhuis WB, van Diest PJ, Pijnappel RM, Witkamp AJ, et al. Radioactive seed localization for non-palpable breast cancer. Br J Surg. 2013;100(5):582–8.PubMedCrossRefGoogle Scholar
  19. 19.
    Ocal K, Dag A, Turkmenoglu O, Gunay EC, Yucel E, Duce MN. Radioguided occult lesion localization versus wire-guided localization for non-palpable breast lesions: randomized controlled trial. Clinics (Sao Paulo). 2011;66(6):1003–7.PubMedPubMedCentralCrossRefGoogle Scholar
  20. 20.
    Paganelli G, Luini A, Veronesi U. Radioguided occult lesion localization (ROLL) in breast cancer: maximizing efficacy, minimizing mutilation. Ann Oncol. 2002;13(12):1839–40.PubMedCrossRefGoogle Scholar
  21. 21.
    Paredes P, Vidal-Sicart S, Santamaria G, Zanon G, Pons F. Application of the ROLL technique in a case of bilateral multifocal breast cancer. Rev Esp Med Nucl. 2008;27(6):436–9.Google Scholar
  22. 22.
    Chow MP, Hung WK, Chu T, Lui CY, Ying M, Mak KL, et al. Isotope-guided surgery for nonpalpable breast cancer. World J Surg. 2011;35(1):165–9.CrossRefGoogle Scholar
  23. 23.
    Thind CR, Tan S, Desmond S, Harris O, Ramesh HS, Chagla L, et al. SNOLL. Sentinel node and occult (impalpable) lesion localization in breast cancer. Clin Radiol. 2011;66(9):833–9.PubMedCrossRefGoogle Scholar
  24. 24.
    Barentsz MW, van Dalen T, Gobardhan PD, Bongers V, Perre CI, Pijnappel RM, et al. Intraoperative ultrasound guidance for excision of non-palpable invasive breast cancer: a hospital-based series and an overview of the literature. Breast Cancer Res Treat. 2012;135(1):209–19.PubMedCrossRefGoogle Scholar
  25. 25.
    Bernal Sprekelsen J, Lopez-Garcia J, Agramunt Lerma M, Escudero de Fez M. Intraoperative ultrasound: is it the method of choice for the detection of breast lesions? Cir Esp. 2014;92:373–4.CrossRefGoogle Scholar
  26. 26.
    Eggemann H, Costa SD, Ignatov A. Ultrasound-guided versus wire-guided breast-conserving surgery for nonpalpable breast cancer. Clin Breast Cancer. 2016;16(1):e1–6. PubMedCrossRefGoogle Scholar
  27. 27.
    Espinosa-Bravo M, Rubio IT. Intraoperative ultrasound guided breast surgery: paving the way for personalized surgery. Gland Surg. 2016;5(3):366–8.PubMedPubMedCentralCrossRefGoogle Scholar
  28. 28.
    Fortunato L, Penteriani R, Farina M, Vitelli CE, Piro FR. Intraoperative ultrasound is an effective and preferable technique to localize non-palpable breast tumors. Eur J Surg Oncol. 2008;34(12):1289–92.CrossRefGoogle Scholar
  29. 29.
    Ramos M, Diez JC, Ramos T, Ruano R, Sancho M, Gonzalez-Orus JM. Intraoperative ultrasound in conservative surgery for non-palpable breast cancer after neoadjuvant chemotherapy. Int J Surg. 2014;12(6):572–7.PubMedCrossRefGoogle Scholar
  30. 30.
    Rubio IT, Esgueva-Colmenarejo A, Espinosa-Bravo M, Salazar JP, Miranda I, Peg V. Intraoperative ultrasound-guided lumpectomy versus mammographic wire localization for breast cancer patients after neoadjuvant treatment. Ann Surg Oncol. 2016;23(1):38–43. PubMedCrossRefGoogle Scholar
  31. 31.
    Ahmed M, Douek M. Intra-operative ultrasound versus wire-guided localization in the surgical management of non-palpable breast cancers: systematic review and meta-analysis. Breast Cancer Res Treat. 2013;140(3):435–46.PubMedCrossRefGoogle Scholar
  32. 32.
    Feld RI, Rosenberg AL, Nazarian LN, Needleman L, Lev-Toaff AS, Segal SR, et al. Intraoperative sonographic localization of breast masses: success with specimen sonography and surgical bed sonography to confirm excision. J Ultrasound Med. 2001;20(9):959–66. PubMedCrossRefGoogle Scholar
  33. 33.
    Harlow SP, Krag DN, Ames SE, Weaver DL. Intraoperative ultrasound localization to guide surgical excision of nonpalpable breast carcinoma. J Am Coll Surg. 1999;189(3):241–6.Google Scholar
  34. 34.
    Lee KY, Seo BK, Yi A, Je BK, Cho KR, Woo OH, et al. Immersion ultrasonography of excised nonpalpable breast lesion specimens after ultrasound-guided needle localization. Korean J Radiol. 2008;9(4):312–9.PubMedPubMedCentralCrossRefGoogle Scholar
  35. 35.
    Bennett IC, Greenslade J, Chiam H. Intraoperative ultrasound-guided excision of nonpalpable breast lesions. World J Surg. 2005;29(3):369–74.PubMedCrossRefGoogle Scholar
  36. 36.
    Krekel NM, Lopes Cardozo AM, Muller S, Bergers E, Meijer S, van den Tol MP. Optimising surgical accuracy in palpable breast cancer with intra-operative breast ultrasound–feasibility and surgeons’ learning curve. Eur J Surg Oncol. 2011;37(12):1044–50.CrossRefGoogle Scholar
  37. 37.
    Tafra L, Fine R, Whitworth P, Berry M, Woods J, Ekbom G, et al. Prospective randomized study comparing cryo-assisted and needle-wire localization of ultrasound-visible breast tumors. Am J Surg. 2006;192(4):462–70.PubMedCrossRefGoogle Scholar
  38. 38.
    Tafra L, Smith SJ, Woodward JE, Fernandez KL, Sawyer KT, Grenko RT. Pilot trial of cryoprobe-assisted breast-conserving surgery for small ultrasound-visible cancers. Ann Surg Oncol. 2003;10(9):1018–24.PubMedCrossRefGoogle Scholar
  39. 39.
    Sahoo S, Talwalkar SS, Martin AW, Chagpar AB. Pathologic evaluation of cryoprobe-assisted lumpectomy for breast cancer. Am J Clin Pathol. 2007;128(2):239–44.PubMedCrossRefGoogle Scholar
  40. 40.
    Nicolae A, Dillon J, Semple M, Hong NL, Ravi A. Evaluation of a ferromagnetic marker technology for intraoperative localization of nonpalpable breast lesions. AJR Am J Roentgenol. 2019;23:1–7. Google Scholar
  41. 41.
    Cox CE, Garcia-Henriquez N, Glancy MJ, Whitworth P, Cox JM, Themar-Geck M, et al. Pilot study of a new nonradioactive surgical guidance technology for locating nonpalpable breast lesions. Ann Surg Oncol. 2016;23(6):1824–30. PubMedCrossRefGoogle Scholar
  42. 42.
    Dauphine C, Reicher JJ, Reicher MA, Gondusky C, Khalkhali I, Kim M. A prospective clinical study to evaluate the safety and performance of wireless localization of nonpalpable breast lesions using radiofrequency identification technology. AJR Am J Roentgenol. 2015;204(6):W720–3.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Nature Switzerland AG 2020

Authors and Affiliations

  • Bruno D. Fornage
    • 1
  1. 1.The University of Texas MD Anderson Cancer CenterHoustonUSA

Personalised recommendations